“Superlative transactional IP work, especially in cutting-edge technologies, such as blockchain, medical technology and machine learning“ IAM MAGAZINE 2019
December 18, 2019>>
Paz Abercohen, Yuval Horn and Yonatan Levinstein of Horn & Co. represented Raziel Therapeutics in its $22 million series C round, led by Pontifax, with participation from existing investors as well as new investors, Catalyst Fund, Quark venture, Peregrine Investments and Wille AG.
October 10, 2019>>
Yuval Horn will moderate a panel about AI and eHealth disruption in the medical and lifestyle markets with Markus von Fuchs at the upcoming IBA 6th Biennial Technology Law Conference in Berlin.
September 25, 2019>>
Yuval Horn moderated a panel with Rabel Z. Akhund on the regulation of crypto trading platforms.
September 24, 2019>>
Yuval Horn moderated, with Doil Son of Yulchon (Seoul) a panel on Data in M&A at the Annual Meeting of the International Bar Association in Seoul.
September 15, 2019>>
Paz Abercohen of Horn & Co. represented Biolight Life Sciences Ltd. in its investment in Sanoculis Ltd., a medical device company which develops an innovative surgical procedure for treatment of Glaucoma
Proud to be ranked, again, by IAM Magazine (Intellectual Asset Management) as one of top 5 “highly recommended” Israeli firms in intellectual property transactions
Horn & Co. has been recognized by Legal 500 as a “Tier 1” firm in Israel in the field of Healthcare and Life Sciences. Yuval Horn was noted as a Tier I practitioner. Legal 500 notes: “Horn & Co is known for providing top-quality service, particularly to pharmaceutical companies and investors, in relation to IP, commercial agreements, M&A and regulatory matters.” The firm was further recognized as a leading firm in the fields of Hi-tech and start-ups and IP transactions.